Overview of stress echocardiography: Uses, advantages, and limitations

Progress in Cardiovascular Diseases

Volumn 43, Issue 4, 2001, Pages 315-334

  Gottdiener, John S ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ARBUTAMINE; DIPYRIDAMOLE; DOBUTAMINE; VASODILATOR AGENT;

BICYCLE ERGOMETRY; CORONARY ARTERY DISEASE; DOPPLER ECHOCARDIOGRAPHY; HAND GRIP; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE PERFUSION; HUMAN; IMAGE QUALITY; PROGNOSIS; QUALITY CONTROL; REVIEW; STRESS ECHOCARDIOGRAPHY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREADMILL EXERCISE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0035137554     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2001.20502     Document Type: Article

References (99)

1. Assessment of myocardial perfusion with contrast echocardiography at rest and with stress: An emerging technology
2. The effect of coronary occlusion on myocardial contraction
3. Correlation between echocardiographically demonstrated segmental dyskinesis and regional myocardial perfusion
4. Dissociation between regional myocardial dysfunction and ECG changes during myocardial ischemia induced by exercise in patients with angina pectoris
5. M-mode echocardiography in evaluating left ventricular function and surgical risk in patients with coronary artery disease
6. Exercise echocardiography: Detection of wall motion abnormalities during ischemia
7. Dissociation between regional myocardial dysfunction and ECG changes during ischemia in the conscious dog
8. Dynamic exercise echocardiography
9. Left and right heart doppler stress echo in congestive heart failure
10. Assessment of left ventricular ejection dynamics in patients with coronary artery disease during dipyridamole-stress doppler echocardiography
11. Regional wall motion assessment in stress echocardiography by tissue doppler bull's-eyes
12. Stress echocardiography: New techniques
13. Quantitative evaluation of the segmental left ventricular response to dobutamine stress by tissue doppler echocardiography
14. Use of segmental tissue doppler velocity to quantitate exercise echocardiography
15. Influence of dobutamine or exercise stress on the results of pulsed-wave doppler assessment of myocardial velocity
16. Transesophageal dobutamine stress echocardiography for evaluation of patients with coronary artery disease
17. Stress-EkhoKG v opredelenii iokalizatsii i stepeni vyrazhennosti koronarnogo ateroskleroza
18. Evaluation of the extent and timing of the coronary hyperemic response to dipyridamole: A study with transesophageal echocardiography and positron emission tomography with oxygen 15 water
19. Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction
20. Feasibility of real-time 3-dimensional treadmill stress echocardiography
21. The natural history of regional dysfunction in a canine preparation of chronic infarction
22. Noninvasive quantification of experimental canine myocardial infarct size using two-dimensional echocardiography
23. Experimental evaluation of the extent of myocardial dyssynergy and infarct size by two-dimensional echocardiography
24. Serial evaluation of myocardial thickening and thinning in acute experimental infarction: Identification and quantification using two-dimensional echocardiography
25. Relations between 2-dimensional echocardiographic wall thickening abnormalities, myocardial infarct size and coronary risk area in normal and hypertrophied myocardium in dogs
26. Detection of acute myocardial infarction in closed-chest dogs by analysis of regional two-dimensional echocardiographic gray-level distributions
27. Two-dimensional echocardiography in experimental coronary stenosis. II. Relationship between systolic wall thinning and regional myocardial perfusion in severe coronary stenosis
28. Crosssectional echocardiography in acute myocardial infarction: Detection and localization of regional left ventricular asynergy
29. Quantitative detection of regional left ventricular contraction abnormalities by two-dimensional echocardiography. II. Accuracy in coronary artery disease
30. Cross-sectional echocardiographic analysis of the extent of left ventricular asynergy in acute myocardial infarction
31. Immediate diagnosis of acute myocardial infarction by twodimensional echocardiography
32. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms
33. Increased diastolic left ventricular wall thickness during dobutamine stress echocardiography: Effect of afterload
34. Dobutamine-atropine stress echocardiography in asymptomatic healthy individuals. The relativity of stress-induced hyperkinesia
35. Stress functional MRI: Detection of ischemic heart disease and myocardial viability
36. Effect of dobutamine on regional left ventricular function measured by tagged magnetic resonance imaging in normal subjects
37. Two-dimensional echocardiographic analysis of wall motion abnormalities during handgrip exercise in patients with coronary artery disease
38. Two-dimensional doppler echocardiographic correlation of dipyridamole-thallium stress testing with isometric handgrip
39. Comparison of adenosine echocardiography, with and without isometric handgrip, to exercise echocardiography in the detection of ischemia in patients with coronary artery disease
40. Does the combination with handgrip increase the sensitivity of dipyridamole-echocardiography test?
41. Relation between contractile reserve and prognosis in patients with coronary artery disease and a depressed ejection fraction
42. Evaluation of left ventricular performance in coronary heart disease: Use of isometric handgrip stress test
43. Safety of dobutamine-atropine stress echocardiography: A prospective experience of 4033 consecutive studies
44. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test
45. The relationship between ambulatory blood pressure and echocardiographically assessed left ventricular hypertrophy
46. Safety of dobutamine stress echocardiography in patients with left ventricular apical thrombus
47. Safety of performing dobutamine stress echocardiography in patients with abdominal aortic aneurysm > or = 4 cm in diameter
48. Chronotropic response, safety, and accuracy of dobutamine stress echocardiography in patients with atrial fibrillation and known or suspected coronary artery disease
49. Safety and efficacy of closed-loop arbutamine stress echocardiography for detection of coronary artery disease
50. Arbutamine echocardiography: Efficacy and safety of a new pharmacologic stress agent to induce myocardial ischemia and detect coronary artery disease. The international arbutamine study group
51. Adequacy of low-stress arbutamine to provoke myocardial ischemia during echocardiography, international arbutamine study group
52. Dipyridamole stress echocardiography
53. Dipyridamole stress echocardiography
54. Exercise-induced ischemia in mildly symptomatic patients with coronary-artery disease and preserved left ventricular function. Identification of subgroups at risk of death during medical therapy
55. Stress echocardiography for evaluation of hemodynamics: Valvular heart disease, prosthetic valve function, and pulmonary hypertension
56. Stress echocardiography in valvular heart disease
57. Functional evaluation of the bileaflet mechanical valve in the aortic position using dobutamine-stress echocardiography: Is a 23-mm prosthetic valve adequately large enough?
58. Aortic valve resistance as an adjunct to the gorlin formula in assessing the severity of aortic stenosis in symptomatic patients
59. Flow dependence of measures of aortic stenosis severity during exercise
60. Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients
61. Dobutamine stress doppler hemodynamics in patients with aortic stenosis: Feasibility, safety, and surgical correlations
62. Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve: A doppler echocardiographic study
63. Exercise doppler echocardiography as an aid to clinical decision making in mitral valve disease
64. Determinants of stroke volume response to exercise in patients with mitral stenosis: A doppler echocardiographic study
65. Doppler echocardiographic estimation of mitral valve area during changing hemodynamic conditions
66. Perioperative cardiac morbidity
67. Dipyridamole thallium-201 scintigraphy as a preoperative screening test. A reexamination of its predictive potential
68. Stress echocardiography with non-exercise techniques
69. Assessment of cardiac risk before nonvascular surgery: Dobutamine stress echocardiography in 530 patients
70. Dobutamine stress echocardiography predicts cardiac events in heart transplant patients
71. Assessment of the progression of cardiac allograft vasculopathy by dobutamine stress echocardiography
72. Role of dobutamine stress echocardiography for diagnosis of cardiac allograft vasculopathy
73. Erste Erfahrungen mit der Dobutamin-Belastungsechokardiographie bei herztransplantierten Patienten
74. Prognostic value of noninvasive testing one year after orthotopic cardiac transplantation
75. Dobutamine stress echocardiography for assessing coronary artery disease after transplantation in children
76. Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: A comparison with coronary angiography and intravascular ultrasound
77. Functional and morphological findings in heart transplant recipients with a normal coronary angiogram: An analysis by dobutamine stress echocardiography, intracoronary doppler and intravascular ultrasound
78. Dobutamine stress echocardiography for noninvasive diagnosis of cardiac allograft vasculopathy: A comparison with angiography and intravascular ultrasound
79. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 spect, thallium-201 stress-reinjection spect and dobutamine echocardiography
80. Dobutamine stress echocardiography and technetium-99m-tetrofosmin/fluorine 18-fluorodeoxyglucose single-photon emission computed tomography and influence of resting ejection fraction to assess myocardial viability in patients with severe left ventricular dysfunction and healed myocardial infarction
81. Dobutamine stress echocardiography at 7.5 mg/kg/min using color tissue doppler imaging m-mode safely predicts reversible dysfunction early after reperfusion in patients with acute myocardial infarction
82. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms
83. Physiological assessment of sensitivity of noninvasive testing for coronary artery disease
84. Comparison of dipyridamole-echocardiography with dipyridamole-thallium scintigraphy for the diagnosis of myocardial ischemia
85. Exercise echocardiography and technetium- 99m mibi singlephoton emission computed tomography in the detection of coronary artery disease
86. Relationship between exercise echocardiography and perfusion single-photon emission computed tomography in patients with single-vessel coronary artery disease
87. Assessment of left ventricular wall motion in angina pectoris by two-dimensional echocardiography and myocardial perfusion by technetium-99m sestamibi tomography during adenosine-induced coronary vasodilation and comparison with coronary angiography
88. Simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery disease
89. Value of dobutamine technetium-99m-sestamibi spect and echocardiography in the detection of coronary artery disease compared with coronary angiography
90. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion, comparison of dobutamine and adenosine using echocardiography and 99mtc-mibi single photon emission computed tomography
91. Exercise echocardiography versus 201TI single-photon emission computed tomography in evaluation of coronary artery disease. Analysis of 292 patients
92. Comparative evaluation of bicycle and dobutamine stress echocardiography with perfusion scintigraphy and bicycle electrocardiogram for identification of coronary artery disease
93. Exercise thallium scintigraphy versus high-dose dipyridamole echocardiography testing for detection of asymptomatic restenosis in patients with positive exercise tests after coronary angioplasty
94. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease? Comparison with two-dimensional echocardiography and technetium-99m methoxyl isobutyl isonitrile (mibi) perfusion scintigraphy
95. Dobutamin-stressechokardiographie und perfusionsszintigraphie zur erfassung myokardialer ischamien bei patienten mit und ohne vorausgegangenen myokardinfarkt
96. Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy
97. Head-tohead comparison of exercise stress testing, pharmacologic stress echocardiography, and perfusion tomography as first-line examination for chest pain in patients without history of coronary artery disease
98. High dose dipyridamole myocardial imaging: Simultaneous sestamibi scintigraphy and two-dimensional echocardiography in the detection and evaluation of coronary artery disease
99. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test